$3.5 Million to Study Down Syndrome and the Immune System
What goes wrong in the immune system that causes autoimmune disease or limits its ability to fight infections? That’s the question Bernard Khor, MD, PhD, started with 12 years ago. His search for answers led him somewhere unexpected: to people with Down syndrome.
Using AI and VR to Advance Research
Caroline Stefani, PhD, became fascinated with the immune system while pursuing her doctorate in microbiology. She loved using imaging tools to examine the worlds of cells and bacteria. But one thing frustrated her.
Immunology to Change Lives: Where We're Going in 2023
BRI was formed with a clear plan: First, answer key fundamental questions about the immune system. Then, build on those answers to change lives. This is a very exciting time because we’re reaching that second stage of the plan.
Teplizumab FAQ: Your Questions Answered About New Therapy to Delay T1D
Scientists at the Benaroya Research Institute (BRI) and TrialNet, a global type 1 diabetes (T1D) research consortium, have spent decades working to answer a bold question: Can we stop T1D before it starts?
Paving the Way for New Colon Cancer Treatments
Steven Ziegler, PhD, still has questions about a protein called thymic stromal lymphopoietin (TSLP) — even after studying it for more than 30 years. The Ziegler Lab helped establish that TSLP plays a role in asthma, lupus and several cancers.
Unmasking Lupus: The Great Masquerader
Hayley Waterman was in college when her mom was diagnosed with a mixed connective tissue autoimmune disease. “It’s similar to lupus but even more vague in definition,” Hayley says.
Exploring New Frontiers of Skin Immunology
Immune cells perform different functions in different parts of the body. Some fight off infections in the skin. Others protect the lungs from pollutants. But how do these cells learn to do the right job in the right place? And why does that process sometimes go wrong?
Clues into Crohn's: Exploring Why the Immune System Attacks Beneficial Bacteria
Your gut is home to a huge community of bacteria called the microbiome. Some bacteria are good, some are bad — and some might hold the key to understanding an inflammatory bowel disease (IBD) like Crohn’s disease and ulcerative colitis.
COVID-19 Hybrid Immunity Study: 3 Key Findings
As an immunologist focused on skin-related autoimmune diseases, Peter Morawski, PhD, never thought he’d study viruses. Then the pandemic hit. “It was this crazy, chaotic time. Everything came second to wanting to help,” he says.
What does it mean for COVID-19 to be endemic?
As the next chapter of COVID-19 unfolds, we’re hearing that the virus will likely become endemic (in the northern hemisphere) — and it will be part of life for the foreseeable future.